Correlation Between Aarey Drugs and UCO Bank
Specify exactly 2 symbols:
By analyzing existing cross correlation between Aarey Drugs Pharmaceuticals and UCO Bank, you can compare the effects of market volatilities on Aarey Drugs and UCO Bank and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aarey Drugs with a short position of UCO Bank. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aarey Drugs and UCO Bank.
Diversification Opportunities for Aarey Drugs and UCO Bank
0.89 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Aarey and UCO is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Aarey Drugs Pharmaceuticals and UCO Bank in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UCO Bank and Aarey Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aarey Drugs Pharmaceuticals are associated (or correlated) with UCO Bank. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UCO Bank has no effect on the direction of Aarey Drugs i.e., Aarey Drugs and UCO Bank go up and down completely randomly.
Pair Corralation between Aarey Drugs and UCO Bank
Assuming the 90 days trading horizon Aarey Drugs Pharmaceuticals is expected to under-perform the UCO Bank. But the stock apears to be less risky and, when comparing its historical volatility, Aarey Drugs Pharmaceuticals is 1.18 times less risky than UCO Bank. The stock trades about -0.21 of its potential returns per unit of risk. The UCO Bank is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest 4,326 in UCO Bank on December 25, 2024 and sell it today you would lose (508.00) from holding UCO Bank or give up 11.74% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Aarey Drugs Pharmaceuticals vs. UCO Bank
Performance |
Timeline |
Aarey Drugs Pharmace |
UCO Bank |
Aarey Drugs and UCO Bank Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Aarey Drugs and UCO Bank
The main advantage of trading using opposite Aarey Drugs and UCO Bank positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aarey Drugs position performs unexpectedly, UCO Bank can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UCO Bank will offset losses from the drop in UCO Bank's long position.Aarey Drugs vs. Can Fin Homes | Aarey Drugs vs. Clean Science and | Aarey Drugs vs. Syrma SGS Technology | Aarey Drugs vs. Shivalik Bimetal Controls |
UCO Bank vs. SBI Life Insurance | UCO Bank vs. R S Software | UCO Bank vs. Selan Exploration Technology | UCO Bank vs. Nucleus Software Exports |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |